Skip to main content

Table 3 CDH22 hypermethylation as an independent prognostic factor

From: CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Variable

PFS

OS

Hazard ratio

(95% CI)

p value

Hazard ratio

(95% CI)

p value

Age

1.035

(1.005–1.067)

0.021

1.060

(1.026–1.094)

<0.001

Stage

4.149

(1.762–9.772)

0.001

2.450

(0.930–6.453)

0.070

CDH22 hypermethylation

4.289

(1.507–12.209)

0.006

2.498

(0.821–7.601)

0.107

  1. Cox regression model shows the independent effect of each prognostic factor on progression-free survival (PFS) and overall survival (OS). Stage was divided into two categories: early (stages I, IIA and IIB) and advanced (stages IIIA and IIIC). CI confidence interval